Metraipolis › archive › dc_7fda571b4770

Enabling late-stage drug diversification by high-throughput experimentation with geometric deep learning — Europe PMC PMID:37996732

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37996732
DOI
10.1038/s41557-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-10-08T17:17:55.939Z
SHA-256 of the archived text
d9389b689772e74d223c1b7f6c0a4d50d1cb935844210ed929c82d8d33bacad8
Stable URL of this page
https://metraipolis.com/documento/dc_7fda571b4770

How to cite

Enabling late-stage drug diversification by high-throughput experimentation with geometric deep learning — Europe PMC PMID:37996732 — Europe PMC (en), https://europepmc.org/article/MED/37996732 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7fda571b4770 (Metraipolis archive dc_7fda571b4770, sha256 d9389b689772e74d223c1b7f6c0a4d50d1cb935844210ed929c82d8d33bacad8)
BibTeX
@misc{dc7fda571b4770,
  title = {Enabling late-stage drug diversification by high-throughput experimentation with geometric deep learning — Europe PMC PMID:37996732},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37996732},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7fda571b4770; sha256 d9389b689772e74d223c1b7f6c0a4d50d1cb935844210ed929c82d8d33bacad8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/37996732. Agents can read the archived copy with the MCP tool read_document.